Hauptseite > Publikationsdatenbank > Lymphocyte antigens targetable by monoclonal antibodies in non-systemic vasculitic neuropathy > print |
001 | 835112 | ||
005 | 20210129230823.0 | ||
024 | 7 | _ | |a 10.1136/jnnp-2017-315878 |2 doi |
024 | 7 | _ | |a 0022-3050 |2 ISSN |
024 | 7 | _ | |a 0266-8637 |2 ISSN |
024 | 7 | _ | |a 0368-329X |2 ISSN |
024 | 7 | _ | |a 1468-330X |2 ISSN |
024 | 7 | _ | |a WOS:000407777300010 |2 WOS |
024 | 7 | _ | |a 2128/22022 |2 Handle |
024 | 7 | _ | |a altmetric:20592135 |2 altmetric |
024 | 7 | _ | |a pmid:28550073 |2 pmid |
037 | _ | _ | |a FZJ-2017-04980 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Schneider, Christian |0 P:(DE-Juel1)158077 |b 0 |
245 | _ | _ | |a Lymphocyte antigens targetable by monoclonal antibodies in non-systemic vasculitic neuropathy |
260 | _ | _ | |a London |c 2017 |b BMJ Publishing Group |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1554290567_32104 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Objective To identify the most relevant antigens for monoclonal antibodies in lymphocytic infiltrates in non-systemic vasculitic neuropathy (NSVN).Background Current immunosuppressive treatment for NSVN is insufficient. Monoclonal antibodies might be a treatment option, but the expression profile for targetable antigens on lymphocytic infiltrates in NSVN is unknown.Methods Sural nerve biopsies from a cohort of patients with NSVN were immunohistochemically studied for the expression of potential candidate antigens in perivascular and intramural lymphocytic infiltrates and correlated with neurological and electrophysiological parameters. 20 patients with treatment naïve NSVN and 5 patients with idiopathic axonal neuropathy were included.Results The CD52, BAFF and CD49d antigens were expressed in epineurial, perivascular or intramural lymphocytes of all (20/20) patients. CD52 was most prominently expressed in 21.49% of all inflammatory infiltrates. BAFF and CD49d were detected in 11.25% and 10.99% of these lymphocytes, respectively. The CD20, CD25 and CD126 antigens were found less frequently and at low levels only (CD20: 10/20 patients, 5.84% of lymphocytes; CD25: 17/20 patients, 5.22% of lymphocytes; CD126: 3/20 patients, 0.15% of lymphocytes).Conclusion This is the first study in NSVN that identifies antigens expressed by pathogenic lymphocytes, which are potential targets for future monoclonal antibody treatment. Our data suggest that NSVN is amenable to monoclonal antibodies and, moreover, that targeting CD52 may be particularly promising. Our results strongly warrant future clinical trials in NSVN with monoclonal antibodies. |
536 | _ | _ | |a 572 - (Dys-)function and Plasticity (POF3-572) |0 G:(DE-HGF)POF3-572 |c POF3-572 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef |
700 | 1 | _ | |a Wunderlich, Gilbert |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Bleistein, Johannes |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Fink, Gereon Rudolf |0 P:(DE-Juel1)131720 |b 3 |
700 | 1 | _ | |a Deckert, Martina |0 P:(DE-HGF)0 |b 4 |
700 | 1 | _ | |a Brunn, Anna |0 P:(DE-HGF)0 |b 5 |
700 | 1 | _ | |a Lehmann, Helmar Christoph |0 P:(DE-HGF)0 |b 6 |e Corresponding author |
773 | _ | _ | |a 10.1136/jnnp-2017-315878 |g p. jnnp-2017-315878 - |0 PERI:(DE-600)1480429-3 |n 9 |p 756–760 |t Journal of neurology, neurosurgery, and psychiatry |v 88 |y 2017 |x 1468-330X |
856 | 4 | _ | |y Published on 2017-05-27. Available in OpenAccess from 2018-11-27. |u https://juser.fz-juelich.de/record/835112/files/756.full.pdf |
856 | 4 | _ | |y Published on 2017-05-27. Available in OpenAccess from 2018-11-27. |x pdfa |u https://juser.fz-juelich.de/record/835112/files/756.full.pdf?subformat=pdfa |
909 | C | O | |o oai:juser.fz-juelich.de:835112 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 3 |6 P:(DE-Juel1)131720 |
913 | 1 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-572 |2 G:(DE-HGF)POF3-500 |v (Dys-)function and Plasticity |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
914 | 1 | _ | |y 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a Embargoed OpenAccess |0 StatID:(DE-HGF)0530 |2 StatID |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J NEUROL NEUROSUR PS : 2015 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a Allianz-Lizenz / DFG |0 StatID:(DE-HGF)0400 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b J NEUROL NEUROSUR PS : 2015 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
920 | _ | _ | |l yes |
920 | 1 | _ | |0 I:(DE-Juel1)INM-3-20090406 |k INM-3 |l Kognitive Neurowissenschaften |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-Juel1)INM-3-20090406 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|